CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 158847-159023 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T69247","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The neuropoietic cytokine oncostatin M (OSM) is expressed in multiple sclerosis (MS) lesions, but its effect on central nervous system (CNS) lesion development remains unknown."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T341","span":{"begin":0,"end":176},"obj":"Epistemic_statement"}],"text":"The neuropoietic cytokine oncostatin M (OSM) is expressed in multiple sclerosis (MS) lesions, but its effect on central nervous system (CNS) lesion development remains unknown."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T59","span":{"begin":0,"end":176},"obj":"Sentence"}],"text":"The neuropoietic cytokine oncostatin M (OSM) is expressed in multiple sclerosis (MS) lesions, but its effect on central nervous system (CNS) lesion development remains unknown."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T614","span":{"begin":81,"end":83},"obj":"Body_part"},{"id":"T615","span":{"begin":112,"end":134},"obj":"Body_part"},{"id":"T616","span":{"begin":120,"end":134},"obj":"Body_part"},{"id":"T617","span":{"begin":136,"end":139},"obj":"Body_part"}],"attributes":[{"id":"A614","pred":"uberon_id","subj":"T614","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A615","pred":"uberon_id","subj":"T615","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A616","pred":"uberon_id","subj":"T616","obj":"http://purl.obolibrary.org/obo/UBERON_0001016"},{"id":"A617","pred":"uberon_id","subj":"T617","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"}],"text":"The neuropoietic cytokine oncostatin M (OSM) is expressed in multiple sclerosis (MS) lesions, but its effect on central nervous system (CNS) lesion development remains unknown."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T68971","span":{"begin":61,"end":79},"obj":"Disease"},{"id":"T77025","span":{"begin":81,"end":83},"obj":"Disease"},{"id":"T16599","span":{"begin":61,"end":79},"obj":"Disease"},{"id":"T92602","span":{"begin":81,"end":83},"obj":"Disease"}],"attributes":[{"id":"A4270","pred":"mondo_id","subj":"T68971","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A26538","pred":"mondo_id","subj":"T77025","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A57502","pred":"mondo_id","subj":"T16599","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A65426","pred":"mondo_id","subj":"T92602","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"The neuropoietic cytokine oncostatin M (OSM) is expressed in multiple sclerosis (MS) lesions, but its effect on central nervous system (CNS) lesion development remains unknown."}